Interaction of KLRG1 with E-cadherin: new functional and structural insights
- PMID: 19009530
- DOI: 10.1002/eji.200838690
Interaction of KLRG1 with E-cadherin: new functional and structural insights
Abstract
The killer cell lectin-like receptor G1 (KLRG1) is an inhibitory receptor expressed by memory T cells and NK cells in man and mice. It is frequently used as a cell differentiation marker and members of the cadherin family are ligands for KLRG1. The present study provides new insights into the interaction of mouse KLRG1 with E-cadherin. Firstly, we demonstrate that co-engagement of KLRG1 and CD3/TCR in a spatially linked manner was required for inhibition arguing against the notion that KLRG1-ligation per se transmits inhibitory signals. Secondly, experiments with T cells carrying Y(7)F-mutant KLRG1 molecules with a replacement of the tyrosine residue to phenylalanine in the single ITIM indicated that the inhibitory activity of KLRG1 is counteracted to some degree by increased interaction of KLRG1(+) T cells with E-cadherin expressing target cells. Thirdly, we demonstrate that deletion of the first or the second external domain of E-cadherin abolished reactivity in KLRG1-reporter cell assays. Finally, we made the intriguing observation that KLRG1 formed multimeric protein complexes in T cells in addition to the previously described mono- and dimeric molecules.
Similar articles
-
Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity.J Exp Med. 2006 Feb 20;203(2):289-95. doi: 10.1084/jem.20051986. Epub 2006 Feb 6. J Exp Med. 2006. PMID: 16461340 Free PMC article.
-
The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo.Eur J Immunol. 2010 May;40(5):1303-14. doi: 10.1002/eji.200939771. Eur J Immunol. 2010. PMID: 20201037
-
Functional plasticity and robustness are essential characteristics of biological systems: lessons learned from KLRG1-deficient mice.Eur J Immunol. 2010 May;40(5):1241-3. doi: 10.1002/eji.201040506. Eur J Immunol. 2010. PMID: 20373518 Review.
-
KLRG1 binds cadherins and preferentially associates with SHIP-1.Int Immunol. 2007 Apr;19(4):391-400. doi: 10.1093/intimm/dxm004. Epub 2007 Feb 16. Int Immunol. 2007. PMID: 17307799
-
Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.IUBMB Life. 2009 Jun;61(6):579-90. doi: 10.1002/iub.208. IUBMB Life. 2009. PMID: 19472182 Review.
Cited by
-
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study.Cell Res. 2022 Nov;32(11):995-1007. doi: 10.1038/s41422-022-00721-y. Epub 2022 Sep 23. Cell Res. 2022. PMID: 36151216 Free PMC article. Clinical Trial.
-
Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling.Blood. 2009 Dec 17;114(26):5299-306. doi: 10.1182/blood-2009-06-228353. Epub 2009 Oct 23. Blood. 2009. PMID: 19855082 Free PMC article.
-
KLRG1 impairs regulatory T-cell competitive fitness in the gut.Immunology. 2017 Sep;152(1):65-73. doi: 10.1111/imm.12749. Epub 2017 Jun 20. Immunology. 2017. PMID: 28437578 Free PMC article.
-
Ptpn2 and KLRG1 regulate the generation and function of tissue-resident memory CD8+ T cells in skin.J Exp Med. 2021 Jun 7;218(6):e20200940. doi: 10.1084/jem.20200940. J Exp Med. 2021. PMID: 33914023 Free PMC article.
-
Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.Oncotarget. 2019 Feb 15;10(14):1399-1406. doi: 10.18632/oncotarget.26659. eCollection 2019 Feb 15. Oncotarget. 2019. PMID: 30858925 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
